Barchart Demo Center

Overview

Stocks

Stock Screeners

ETFs

Futures

Funds

Fund Screeners

Foreign Exchange

Sectors

News

Financial Calculators

Embedded Widgets

Portfolio

Screener

JSON Feeds

Symbol Overview

United States|Canada
English|French

Evelo Biosciences Inc

(NASDAQ: EVLO)
Add to Portfolio
-0.07 (-1.03%)
as of 12:46 EST

Last 6.71
Change -0.07 (-1.03%)
Open 6.83
Prev. Close 6.78
Today's Range
6.27
6.83
52wk Range
3.58
10.09
Volume 75,659
Avg Volume 97,718
Sector SIC-2834 Pharmaceutical Preparations

Perfomance Comparison

Name Today 3-Month 1-Year
EVLO -1.03% +3.79% -25.59%
DJIA +0.85% +3.54% +17.29%
S&P 500 +1.11% +5.97% +24.02%

Key Statistics

Annual EPS -2.45
Dividend Yield 0.00%
P/E Ratio N/A
Market Capitalization, $K 192,840
Weighted Alpha -46.80
Standard Deviation -0.52
Profit Margin N/A
Beta -0.35

Growth Rates

YTD +61.82%
1-Year -24.75%

Opinion

Sell Hold Buy

Recent Headlines

Evelo Provides Update on Recent Positive EDP1815

GlobeNewswire via COMTEX - Fri Jan 10, 07:00AM EST
-- EDP1815 Phase 2 Interim Data in Psoriasis Expected by Year-End 2020 --(full story)
EVLO: 6.71 (-0.07)

Flagship Unveils Newest Pioneering Platform: Ring

PR Newswire via COMTEX - Thu Dec 19, 08:00AM EST
Flagship Pioneering, a unique life sciences innovation enterprise, today announced the launch of Ring Therapeutics, an early-stage biotechnology company developing first-in-class gene therapies using a new viral vector platform ba(full story)
AXLA: 5.24 (unch), DNLI: 26.01 (-1.97), EVLO: 6.71 (-0.07), KLDO: 8.39 (-0.81), MRNA: 22.42 (-0.32), RUBY: 7.96 (-0.01), MCRB: 3.25 (+0.03)

Flagship Pioneering Strengthens Leadership With

PR Newswire via COMTEX - Mon Dec 16, 09:25AM EST
Flagship Pioneering, a unique life sciences innovation enterprise, today announced the appointment of Paul Biondi to the post of Executive Partner. Mr. Biondi most recently served as Senior Vice President, Head of Strategy and Bus(full story)
BMY: 65.19 (+1.49), AXLA: 5.24 (unch), DNLI: 26.01 (-1.97), EVLO: 6.71 (-0.07), KLDO: 8.39 (-0.81), MRNA: 22.42 (-0.32), RUBY: 7.96 (-0.01)

Evelo Biosciences Appoints Juan Andres to Board of

GlobeNewswire via COMTEX - Thu Dec 05, 07:00AM EST
Evelo Biosciences, Inc. (Nasdaq:EVLO), a clinical stage biotechnology company developing a new modality of orally delivered, systemically acting biologics, today announced the appointment of biopharmaceutical industry veteran Juan(full story)
LLY: 139.30 (+0.99), EVLO: 6.71 (-0.07)

Flagship Pioneering Names Dr. Nancy Simonian, CEO of

PR Newswire via COMTEX - Mon Dec 02, 01:51PM EST
Flagship Pioneering has announced the recipient of the firm's annual Pioneering Leader Award. The 2019 award recognizes Nancy Simonian, M.D., CEO of Syros Pharmaceuticals (NASDAQ: SYRS), a company that is redefining the power of s(full story)
AXLA: 5.24 (unch), DNLI: 26.01 (-1.97), EVLO: 6.71 (-0.07), KLDO: 8.39 (-0.81), MRNA: 22.42 (-0.32), RUBY: 7.96 (-0.01), MCRB: 3.25 (+0.03)